Fungi are important causes of keratitis, especially in countries with a tropical climate. The organism group accounts for nearly 40% of all isolates from corneal ulcer cases. [1, 2] In the last decade, we have witnessed a lot of interest in the study of infections caused by fungi. The outbreak of Fusarium keratitis in contact lens users probably provided stimulus in generating this interest and necessary financial support. One of the fields that got attention of researchers is improvement in the identification of fungal isolates.
Classically, most laboratories use culture characteristics and morphology of spores for the identification of fungal isolates. Unfortunately, samples positive for fungus on microscopic examination might fail to grow on culture. Further, colonies on culture media might fail to sporulate. Both these factors result in a significant proportion of fungi remaining unidentified or isolates identified to the genus level only.
It is increasingly being recognized that accurate diagnosis of fungi to species level will throw new light in understanding the epidemiology, drug susceptibility, and treatment outcomes of mycotic keratitis cases. The most commonly used technique for species identification is sequence-based molecular identification, wherein a fragment from a specific locus is amplified by polymerase chain reaction (PCR), followed by the analysis of the resulting sequence with a nucleotide-nucleotide BLAST search in the nucleotide sequence collection of the National Center for Biotechnology Information (NCBI). The locus most frequently applied for species identification is the internal transcribed spacer (ITS) region of the ribosomal RNA gene cluster (rDNA). The application of this approach has resulted in the identification of several uncommon fungi from keratitis cases. Prominent among these isolates are Lagenidium and Pythium species from the Oomycota division. [3] Using these techniques, an Indo-Hungarian Fungal Keratitis (IHFK) Working Group demonstrated an impressive phylogenetic diversity of the genus Fusarium causing human keratomycosis in South India. [4] The diversity was reflected in antimicrobial susceptibility as well. The group highlighted the need for species-level identification of fungal isolates both for understanding precise epidemiology as well as appropriate drug treatment.
In this issue of the journal, you will find an article [5] where authors described a case of keratitis caused by a plant pathogen Pseudopestalotiopsis theae. The organism belongs to Pestalotiopsis group that contains two genera Neopestalotiopsis and Pseudopestalotiopsis. This is probably the first report of human infection caused by the organism and the precise identification was possible because of the use of molecular technique. The case reiterates the importance of definitive diagnosis of fungal isolates to species level.
To conclude, because in India fungi play an important role in the causation of keratitis, a potentially blinding disorder, it is time that few well-established laboratories must start adopting techniques that help identifying fungal isolates to species levels on a routine basis. This combined with antimicrobial susceptibility will help better define the epidemiology, medical management, and help understand the causes of treatment failure besides identifying uncommon pathogens. 
Prashant Garg

Vitamin D supplementation in patients with xeroderma pigmentosum
Dear Sir, Xeroderma pigmentosum (XP) is an autosomal recessive disorder of DNA repair mechanism that results in damaging effects on sun-exposed parts of the body. [1] [2] [3] A review of 100 patients with XP revealed that they never received vitamin D supplementation, although they had consulted dermatologists, physicians, and pediatricians in the past. It was also observed that many in their adulthood had short statures and were noticeably shorter than their unaffected parents.
We evaluated and compared stature of XP patients with age-matched normal Indian population obtained from literature. [4] Further, we studied serum vitamin D levels in 14 patients including children <18 years. Vitamin D levels were evaluated using chemiluminescence assay (levels <10 and 10-20 ng/ml were reported as vitamin D deficiency and vitamin D insufficiency, respectively). S t a t u r e o f 3 1 a d u l t p a t i e n t s [ m e d i a n a g e 28 years (interquartile range, 23-31 years)] was examined by internists. Nineteen were males (61.3%). Both males and females were significantly shorter when compared with age-matched normal population [ Table 1 ]. Mean height deficits in males and females were 6.7 and 5.9 cm, respectively, and were independent of age (P = 0.81 and P = 0.13, respectively, Spearman correlation). Per a simpler classification, [4] 73.7% of males and 75% of females were shorter, whereas Hadj-Rabia et al. showed ~52%. [5] Median serum vitamin D3 was 8.65 ng/ml (interquartile range, 7.37-10.81 ng/ml). None of the patients had vitamin D supplementation at presentation or before.
The study reveals that patients with XP have shorter statures and are vitamin D deficient. Although specific factors contributing to a stunted growth cannot be investigated, it is presumed that a vitamin D deficiency during growth period could be attributed to the failure of attaining a normal stature. Since XP patients visit a dermatologist, ophthalmologist, pediatrician, or physician based upon their initial complaints, it is important to sensitize all healthcare providers about the need for vitamin D supplementation in the routine care and follow-up of these patients.
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